LOGIN OR REGISTER
Course Library

Treatment of Multiple Myeloma in the First-Line, Maintenance, and Relapsed/Refractory Settings

Hematology-Oncology
Curriculum:
Multiple Myeloma: A CE-Certified Serial Learning Approach to Bridging Communication and Educational Gaps in MM
Credits:
1 ANCC Contact Hours
Launch Date:
September 08, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Oncology/Hematology Nurses

Relevant Terms:

Multiple Myeloma

Beth Faiman, PhD, RN, APRN-BC, AOCN®

Beth Faiman, PhD, RN, APRN-BC, AOCN®
Adult Nurse Practitioner, Department of Hemtologic Oncology and Blood Disorders
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio
Adjunct Faculty
Ursuline College
Case Western Reserve University
Kent State University
Kent, Ohio

Dr. Beth Faiman is an Adult Nurse Practitioner in the Department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic Taussig Cancer Institute in Ohio. She is an Adjunct Faculty member at Ursuline College, Case Western Reserve University, and Kent State University, as well as an appointed delegate on the International Myeloma Foundation Nurse Leadership Board.
 
Dr. Faiman is an active author, presenter, and educator on the topics of multiple myeloma, plasma cell dyscrasias, general cancer diagnosis and treatment, as well as management of skeletal and other cancer complications. Dr. Faiman is currently editor-in-chief of The Oncology Nurse - APN/PA. She has edited books and written several book chapters related to diagnosis and management of multiple myeloma and blood disorders and numerous articles related to the diagnosis and treatment of myeloma, palliation, and cancer symptom management.
 
Dr. Faiman earned an MSN and certification as an adult nurse practitioner from Kent State University, Ohio, and a PhD in clinical research and nursing science from Case Western Reserve University in Cleveland, Ohio. She is an advanced oncology certified nurse.

Sandra E. Kurtin, MS, RN, ANP-C, AOCN®

Sandra E. Kurtin, MS, RN, ANP-C, AOCN®
Nurse Practitioner
Clinical Assistant Professor of Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona Cancer Center
Tucson, Arizona

Sandra E. Kurtin is a Nurse Practitioner, Clinical Assistant Professor of Medicine, and Adjunct Clinical Assistant Professor of Nursing at The University of Arizona Cancer Center in Tucson.

Ms. Kurtin maintains a busy clinical practice in a National Cancer Institute–designated comprehensive cancer center with expertise in hematological malignancies, gastrointestinal malignancies, clinical trials, symptom management, cancer caregivers, and health informatics.
 
Ms. Kurtin is widely published in peer-reviewed journals, lectures nationally and internationally, and maintains active membership in local, regional, national, and international professional and patient advocacy oncology organizations.
 
Ms. Kurtin earned an MSN from The University of Arizona in Tucson and is an advanced oncology certified nurse. She is currently enrolled in the PhD program with a focus on nursing and health informatics.
1. Assess the latest data on the safety and efficacy of current and emerging treatment options in the newly diagnosed, maintenance, and relapsed/refractory disease settings
2. Describe education strategies to help patients understand their treatment options
3. Develop an evidence-based nursing care plan for patients with multiple myeloma based on disease- and treatment-related symptoms

Activity Overview
The treatment armamentarium for multiple myeloma (MM) has expanded significantly in recent years, with 4 new therapies approved by the US Food and Drug Administration in 2015 alone. Additionally, best practices and consensus guidelines for MM are continually evolving as new data are published. This activity will review current treatment approaches and guidelines/recommendations for newly diagnosed and relapsed/refractory MM, recent clinical trial data on novel and emerging therapies, and dosage/administration strategies for these therapies.
 
The AXIS Medical Education ACE Program in MM provides a focused, interactive, peer-to-peer educational experience for 20 ACE candidates, leading to ACE status. The objective of the program is not only to improve ACE candidates’ knowledge, competency, and level of performance in the treatment and management of MM, but also to build their skills as subject matter experts and speakers in this therapeutic area.
 
This self-study activity was completed by ACE candidates enrolled in the ACE program and is now available to oncology nurses who were unable to participate in the ACE program. AXIS will compare the gains achieved within the activity by the ACE candidates with those learners participating outside of the program to demonstrate the value in improving knowledge, confidence, competence, performance, and retention by participating in the ACE program.
 
This activity was released on September 8th, 2016 and is valid until September 7th, 2017. Requests for credit must be made no later than September 7th, 2017.
 
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
 
This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
Global Contact Information 
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.
 
Instructions to Receive Credit 
To receive credit for this activity, the participant must read the learning objectives and faculty disclosures and study the educational activity.  
 
Upon successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.
 
Disclosure of Conflicts of Interest 
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Faculty or Presenter Reported Financial Relationship
Beth Faiman, PhD, MSN, APRN-BC, AOCN®
Consultant/Independent contractor: Celgene Corporation; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.;
Speakers' bureau: Celgene Corporation; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
Sandra E. Kurtin, MS, RN, ANP-C, AOCN®
Consultant/Independent contractor: Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited;
Honoraria: Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited.
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Planner or Manager
Reported Financial 
Relationship
Ashley Marostica, RN, MSN  Nothing to disclose
Amanda Glazar, PhD Nothing to disclose
Andrea Funk Nothing to disclose
Laura Gilsdorf Nothing to disclose
Linda Gracie-King, MS Nothing to disclose
Ronald Viggiani, MD Nothing to disclose
Isabelle Vacher Nothing to disclose
Jocelyn Timko, BS Nothing to disclose
 
Disclosure of Unlabeled Use 
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and AXIS Medical Education do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Disclaimer 
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 
This activity is supported by educational grants provided by Celgene Corporation, Novartis Pharmaceuticals, and Takeda Oncology.
 
There is no fee for this educational activity.
 
This activity is provided by
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Home About Us Privacy Policy Terms of Service Permissions Employment Contact Us Mobile Terms

© Copyright 2024 AXIS Medical Education, Inc. (AXIS). All Rights Reserved.

Schedule an event with a Standardized Patient
×